Recruiting
the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
NCT06622603
- Conditions
- Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +10 more
- Locations
-
- Seoul National University Bundang Hospital Seongnam-si, Gyeonggi-do, South Korea